Literature DB >> 19454705

The UDP-glucose receptor P2RY14 triggers innate mucosal immunity in the female reproductive tract by inducing IL-8.

Toru Arase1, Hiroshi Uchida, Takashi Kajitani, Masanori Ono, Kayoko Tamaki, Hideyuki Oda, Sayaka Nishikawa, Maki Kagami, Takashi Nagashima, Hirotaka Masuda, Hironori Asada, Yasunori Yoshimura, Tetsuo Maruyama.   

Abstract

Innate mucosal immune responses, including recognition of pathogen-associated molecular patterns through Toll-like receptors, play an important role in preventing infection in the female reproductive tract (FRT). Damaged cells release nucleotides, including ATP and uridine 5'-diphosphoglucose (UDP-glucose), during inflammation and mechanical stress. We show in this report that P2RY14, a membrane receptor for UDP-glucose, is exclusively expressed in the epithelium, but not the stroma, of the FRT in humans and mice. P2RY14 and several proinflammatory cytokines, such as IL-8, are up-regulated in the endometria of patients with pelvic inflammatory disease. UDP-glucose stimulated IL-8 production via P2RY14 in human endometrial epithelial cells but not stromal cells. Furthermore, UDP-glucose enhanced neutrophil chemotaxis in the presence of a human endometrial epithelial cell line in an IL-8-dependent manner. Administration of UDP-glucose into the mouse uterus induced expression of macrophage inflammatory protein-2 and keratinocyte-derived cytokine, two murine chemokines that are functional homologues of IL-8, and augmented endometrial neutrophil recruitment. Reduced expression of P2RY14 by small interfering RNA gene silencing attenuated LPS- or UDP-glucose-induced leukocytosis in the mouse uterus. These results suggest that UDP-glucose and its receptor P2RY14 are key front line players able to trigger innate mucosal immune responses in the FRT bypassing the recognition of pathogen-associated molecular patterns. Our findings would significantly impact the strategic design of therapies to modulate mucosal immunity by targeting P2RY14.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19454705     DOI: 10.4049/jimmunol.0900001

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

Review 1.  Signalling and pharmacological properties of the P2Y receptor.

Authors:  T K Harden; J I Sesma; I P Fricks; E R Lazarowski
Journal:  Acta Physiol (Oxf)       Date:  2010-03-24       Impact factor: 6.311

2.  GPR105 ablation prevents inflammation and improves insulin sensitivity in mice with diet-induced obesity.

Authors:  Jianfeng Xu; Hidetaka Morinaga; Dayoung Oh; Pingping Li; Ai Chen; Saswata Talukdar; Yaël Mamane; Joseph A Mancini; Andrea R Nawrocki; Eduardo Lazarowski; Jerrold M Olefsky; Jane J Kim
Journal:  J Immunol       Date:  2012-07-09       Impact factor: 5.422

3.  P2Y14 Receptor Antagonists Reverse Chronic Neuropathic Pain in a Mouse Model.

Authors:  Fatma Mufti; Young-Hwan Jung; Luigino Antonio Giancotti; Jinha Yu; Zhoumou Chen; Ngan B Phung; Kenneth A Jacobson; Daniela Salvemini
Journal:  ACS Med Chem Lett       Date:  2020-04-30       Impact factor: 4.345

4.  The nucleotide sugar UDP-glucose mobilizes long-term repopulating primitive hematopoietic cells.

Authors:  Sungho Kook; Joonseok Cho; Sean Bong Lee; Byeong-Chel Lee
Journal:  J Clin Invest       Date:  2013-07-25       Impact factor: 14.808

Review 5.  Purinergic signalling in the reproductive system in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-23       Impact factor: 3.765

6.  Transcriptomic analysis of the interaction of choriocarcinoma spheroids with receptive vs. non-receptive endometrial epithelium cell lines: an in vitro model for human implantation.

Authors:  Paula Vergaro; Gustavo Tiscornia; Amelia Rodríguez; Josep Santaló; Rita Vassena
Journal:  J Assist Reprod Genet       Date:  2019-04-10       Impact factor: 3.412

Review 7.  P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential.

Authors:  Gary A Weisman; Lucas T Woods; Laurie Erb; Cheikh I Seye
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-09       Impact factor: 4.388

Review 8.  UDP-Sugars as Extracellular Signaling Molecules: Cellular and Physiologic Consequences of P2Y14 Receptor Activation.

Authors:  Eduardo R Lazarowski; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2015-03-31       Impact factor: 4.436

9.  Ecto-nucleotidases distribution in human cyclic and postmenopausic endometrium.

Authors:  Elisabet Aliagas; August Vidal; Benjamín Torrejón-Escribano; Maria del Rosario Taco; Jordi Ponce; Inmaculada Gómez de Aranda; Jean Sévigny; Enric Condom; Mireia Martín-Satué
Journal:  Purinergic Signal       Date:  2012-12-06       Impact factor: 3.765

10.  A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils.

Authors:  Matthew O Barrett; Juliana I Sesma; Christopher B Ball; P Suresh Jayasekara; Kenneth A Jacobson; Eduardo R Lazarowski; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2013-04-16       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.